Press Release | July 11, 2024
BIO-CAT is excited to announce the publication of a groundbreaking safety clinical trial manuscript featuring its proprietary enzyme ingredient, OPTIZIOME® Inulinase (now marketed as OPTIZIOME® Fructanase), in Gastro Hep Advances. Read the details here.
